Polysaccharide/inorganic nanoparticles hybrid micron-nano medicine-carrying capsule

A micro-nano and polysaccharide technology, applied in micro-capsules, capsule delivery, inorganic inactive ingredients, etc., can solve the problems of low drug loading rate, use, and difficulty, and achieve high-efficiency drug in-situ encapsulation, good biological Compatibility and biodegradability, the effect of good biodegradability

Active Publication Date: 2010-05-12
HANGZHOU NORMAL UNIVERSITY
View PDF6 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The process of preparing pure polyelectrolyte capsules and polyelectrolyte/inorganic nanoparticle hybrid or pure inorganic nanoparticle capsules by the LbL method is generally as follows: first, the suspension of colloidal particles is added to an excess polyelectrolyte solution that is opposite to the polarity of its surface charge. In the process, a layer of oppositely charged polyelectrolyte layer is adsorbed on the surface of colloidal particles by electrostatic mutual attraction; excess polyelectrolyte is removed by centrifugation and washing. Then another polyelectrolyte solution or inorganic nanoparticle sol with opposite charge is selected , repeat the above process to make polyelectrolyte or inorganic nanoparticles adsorb alternately on the surface of the colloidal particles to form a multilayer film. The core-shell structure particles prepared by the LbL method can be obtained by dissolving or burning the core to remove the core. Capsules with nanometer or micron-diameter cavities. For example, the international patent (WO99/47252) uses negatively charged polystyrene sulfonate sodium (PSS) and positively charged polystyrene amine (PAH) in melamine formaldehyde microspheres (MF). Multi-layer coating, and finally use hydrogen fluoride to remove MF to obtain hollow polymer capsules; the disadvantage of the above patents is that MF templates n...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polysaccharide/inorganic nanoparticles hybrid micron-nano medicine-carrying capsule

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1: take elemene, OSA modified starch sodium solution as an example to illustrate

[0034] At normal temperature, the fat-soluble drug elemene is added to the 5wt% OSA modified starch aqueous solution, the concentration is controlled at 5wt%, vigorously mechanically stirred under the condition of 15000-18000rpm, and then the above-mentioned crude emulsion is added into the high-pressure homogenizer ( 100bar) homogenized 4 times to obtain nanoemulsion.

Embodiment 2

[0035] Embodiment 2: Take paclitaxel / medium chain triglyceride, OSA modified starch sodium solution as an example for illustration

[0036] 5 g of paclitaxel was dissolved in 50 ml of medium-chain triglyceride (Miglyol 812, Shanghai Sinopharm Chemical Reagent Co., Ltd.), and stirred thoroughly to obtain a 10 wt% (w / w) paclitaxel oil phase solution. At room temperature, add 50mL of 10wt% (w / w) paclitaxel solution prepared into 50mL of OSA modified starch (5wt%) aqueous medium, vigorously stir mechanically at 15000-18000rpm, then add the above crude emulsion Homogenize 4 times in a high-pressure homogenizer (100 bar) to obtain a nanoemulsion.

Embodiment 3

[0037] Embodiment 3: illustrate with zedoary oil, OSA modified starch sodium solution.

[0038] At normal temperature, zedoary oil was added to OSA modified starch (5wt%) aqueous medium, the concentration was controlled at 10wt%, vigorously mechanically stirred under the condition of 15000~18000rpm, then the above-mentioned coarse emulsion was added in the high-pressure homogenizer ( 100bar) homogenized 4 times to obtain nanoemulsion.

[0039] Two, the preparation of capsule: take the oil phase droplet in the nanoemulsion as soft template, take one or more in chitosan, 2-hydroxypropyl trimethyl chitosan quaternary ammonium salt as polycation, with Sodium alginate, λ-carrageenan, Fe with negatively charged surface 3 o 4 / Fe 2 o 3 One or more of the magnetic nanoparticles and the Au nanoparticles are polyanions, and the hybrid micro-nano drug-loaded capsules are formed under high-pressure homogeneous conditions through layer-by-layer self-assembly.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
The average particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses polysaccharide/inorganic nanoparticles hybrid micron-nano medicine-carrying capsule. The capsule has the following structure characteristics: (1) a water in oil (W/O) microemulsion capsule core is prepared by using fat-soluble drug A or fat-soluble drug B which is dissolved in oily solvent, negative OSA modified polysaccharide derivative and water; (2) the polysaccharide and negative inorganic nanoparticles perform layer-by-layer self-assembly which is based on the electrostatic interaction to form a capsule wall; and (3) the grain size of the micron-nano medicine-carrying capsule is 50-1000nm. The micron-nano medicine-carrying capsule provided by the invention has high drug encapsulation efficiency for drug situ embedding, the raw materials are all adopted from biodegradable materials with good biocompatibility and biodegradability. In addition, the medicine-carrying system has double intelligent functions of targeting and controlled release.

Description

(1) Technical field [0001] The invention relates to a polymer / inorganic nanoparticle hybrid micronano drug-loaded capsule. (2) Background technology [0002] Therapeutic drugs, especially antineoplastic drugs, usually have strong toxic side effects on normal tissues and cells. Therefore, it is of great significance to target the delivery of drugs to the lesion and release them slowly, so as to reduce the distribution and release of drugs in normal tissues. The development of drug delivery system has become a research hotspot in the field of nanomedicine in recent years, and it is one of the ways to fundamentally change the therapeutic effect of drugs. [0003] The common carrier of fat-soluble drugs is liposome, which has a simple preparation process and is mainly formed spontaneously in water by phospholipids through hydrophobic association. Liposomes are thermodynamically unstable colloidal particles that are prone to spontaneous fusion and sedimentation; the membrane st...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/50A61K47/36A61K47/38A61K47/02A61K36/9066A61K31/015A61P35/00
Inventor 梁媛媛黄志坚陈灿玉焦艳华
Owner HANGZHOU NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products